Biogen

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$2,454,800
$2,645,500
$2,431,000
$2,454,700
Gross Profit
1,578,200
1,699,300
1,853,100
1,871,200
EBITDA
826,900
1,109,900
865,100
691,700
EBIT
624,700
915,600
681,900
507,700
Net Income
466,500
634,800
240,500
266,700
Net Change In Cash
2,454,800
2,645,500
2,431,000
2,454,700
Free Cash Flow
1,226,300
144,300
212,200
694,600
Cash
3,862,800
2,758,800
2,598,300
2,375,000
Basic Shares
147,100
145,900
145,900
146,100

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$9,675,900
$9,835,600
$10,173,400
$10,981,700
Gross Profit
7,365,500
7,302,200
7,895,100
8,872,000
EBITDA
2,995,700
2,377,000
3,536,900
3,923,400
EBIT
2,322,500
1,882,200
3,018,500
3,435,700
Net Income
1,632,200
1,161,100
3,046,900
1,556,100
Net Change In Cash
9,675,900
9,835,600
10,173,400
10,981,700
Cost of Revenue
1,213,600
990,000
Free Cash Flow
2,515,700
1,235,800
1,144,000
3,345,000
Cash
2,375,000
1,049,900
3,419,300
2,261,400
Basic Shares
145,900
145,600
146,000
149,600

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$4.81
2025-06-30
$5.47
2025-03-31
$3.02